(Q37453816)

28 September 2017

1 reference

title

High throughput molecular diagnostics in bladder cancer - on the brink of clinical utility (English)

1 reference

28 September 2017

1 reference

Karsten Zieger

1

1 reference

PMC publication ID

5543843

28 September 2017

language of work or name

1 reference

8 December 2007

1 reference

28 September 2017

1 reference

28 September 2017

1

1 reference

28 September 2017

4

1 reference

28 September 2017

384-394

1 reference

Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

SNPTools: a software tool for visualization and analysis of microarray data

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Chromosomal aberrations and gene expression profiles in non-small cell lung cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Clinical utility of microarray-derived genetic signatures in predicting outcomes in prostate cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Microarrays in breast cancer research and clinical practice--the future lies ahead.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Gene expression profiling on lung cancer outcome prediction: present clinical value and future premise.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Whole genome expression analysis for biologic rational pathway modeling: application in cancer prognosis and therapy prediction

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

A gene-expression signature to predict survival in breast cancer across independent data sets.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Concordance among gene-expression-based predictors for breast cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

A combined approach to data mining of textual and structured data to identify cancer-related targets

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Microarrays in gastrointestinal cancer: is personalized prediction of response to chemotherapy at hand?

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

The molecular portraits of breast tumors are conserved across microarray platforms

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Gene expression profiling predicts survival in conventional renal cell carcinoma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Bladder cancer stage and outcome by array-based comparative genomic hybridization

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Bladder cancer outcome and subtype classification by gene expression

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Common denominator procedure: a novel approach to gene-expression data mining for identification of phenotype-specific genes

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

The current status of intravesical therapy for superficial bladder cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Gene discovery in bladder cancer progression using cDNA microarrays

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

RhoGDI2 is an invasion and metastasis suppressor gene in human cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

1 October 2017

The Hallmarks of Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

26 June 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

Identifying distinct classes of bladder carcinoma using microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

A simple method for the routine detection of somatic quantitative genetic alterations in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

Urinary biomarker profiling in transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

Validation study of the prediction system for clinical response of M-VAC neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

Chromosomal instability in microsatellite-unstable and stable colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5543843

Prognosis of Muscle-Invasive Bladder Cancer: Difference between Primary and Progressive Tumours and Implications for Therapy

2 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

Prediction of recurrence in Ta urothelial cell carcinoma by real-time quantitative PCR analysis: A microarray validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

Characterizing genetically stable and unstable gastric cancers by microsatellites and array comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2007.11.002

Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer

21 January 2018

1 reference

12 December 2020

Gene Expression Signatures Predict Outcome in Non-Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study

1 reference

12 December 2020

Using tree analysis pattern and SELDI-TOF-MS to discriminate transitional cell carcinoma of the bladder cancer from noncancer patients

1 reference

12 December 2020

Transurethral surgery in the treatment of invasive bladder cancer (T1 and T2)

1 reference

12 December 2020

Prediction of cancer outcome with microarrays: a multiple random validation strategy

1 reference

12 December 2020

Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis

1 reference

12 December 2020

HSP90 expression: a new predictive factor for BCG response in stage Ta-T1 grade 3 bladder tumours

1 reference

12 December 2020

High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors

1 reference

12 December 2020

Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer

1 reference

12 December 2020

Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH

1 reference

12 December 2020

Multiple Gene Expression Classifiers from Different Array Platforms Predict Poor Prognosis of Colorectal Cancer

1 reference

12 December 2020

A Molecular Signature in Superficial Bladder Carcinoma Predicts Clinical Outcome

1 reference

12 December 2020

10.1016/J.MOLONC.2007.11.002

Identifiers

DOI

1 reference

28 September 2017

1 reference

PMC publication ID

5543843

28 September 2017

PubMed publication ID

19383312

1 reference

PMC publication ID

5543843